Protein kinase a RIα antisense inhibition of PC3m prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation

Clinical Cancer Research

Volumn 8, Issue 2, 2002, Pages 607-614

  Cho, Yee Sook ^a   Kim, Meyoung Kon ^a   Tan, Langzhu ^a   Srivastava, Rakesh ^b   Agrawal, Sudhir ^c   Cho Chung, Yoon S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c HYBRIDON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BAD PROTEIN, HUMAN; BAX PROTEIN, HUMAN; CARRIER PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ONCOPROTEIN; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; REGULATORY SUBUNIT RIALPHA, CYCLIC AMP DEPENDENT PROTEIN KINASE; REGULATORY SUBUNIT RIALPHA, CYCLIC-AMP-DEPENDENT PROTEIN KINASE; ANDROGEN; ANTISENSE OLIGODEOXYNUCLEOTIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE RIALPHA; PHOSPHODIESTERASE IV; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL NUCLEUS; DOWN REGULATION; HUMAN; MALE; METABOLISM; NORTHERN BLOTTING; PHOSPHORYLATION; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TIME; UPREGULATION; WESTERN BLOTTING; CANCER CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; GENE OVEREXPRESSION; HORMONE RESISTANCE; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARRIER PROTEINS; CELL NUCLEUS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; HUMANS; MALE; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0036188072     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Identification of 3′5′-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter
2. Second messenger upregulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines, PC-3 and DU-145
3. Analysis of the cAMP-dependent protein kinase system using molecular genetic approaches
4. Altered cellular ratio of type I and type II cyclic AMP-dependent protein kinase in human mammary tumors
5. Types of cyclic AMP binding proteins in human breast cancers
6. Changes in messenger RNA expression of protein kinase A regulatory subunit Iα in breast cancer patients treated with tamoxifen
7. Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: New approaches to therapy
8. Cyclic adenosine 3′,5′-monophosphate-binding proteins in human ovarian cancer: Correlations with clinicopathological features
9. Increased expression of the RIα subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer
10. Regulation of Lewis lung carcinoma invasion and metastasis by protein kinase A
11. Protein kinase A (PK-A) regulatory subunit expression in colorectal cancer and related mucosa
12. Growth-regulatory effects of gastrin on human colon cancer cell lines is determined by protein kinase A isoform content
13. Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue
14. Tumor cyclic AMP binding proteins: An independent prognostic factor for disease recurrence and survival in breast cancer
15. A single-injection protein kinase A-directed antisense treatment to inhibit humor growth
16. Antisense DNA-targeting protein kinase A-RIα subunit. A novel approach to cancer treatment
17. Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIα subunit of protein kinase A after oral administration
18. Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotides targeting protein kinase A
19. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIa subunit
20. Overexpression of RII β regulatory subunit of protein kinase A in human colon carcinoma cell induces growth arrest and phenotypic changes that are abolished by site-directed mutation of RII β
21. Growth arrest and induction of apoptosis in breast cancer cells by antisense depletion of protein kinase A-RIα subunit: p53-independent mechanism of action
22. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase
23. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A
24. Site of chemical modifications in CpG containing phosphorothioate oligodeoxynucleotide modulates its immunostimulatory activity
25. A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM 231) targeting the type I protein kinase A by 2-hour infusions in patients with refractory solid tumors
26. CpG motifs in bacterial DNA trigger direct B-cell activation
27. An antisense oligodeoxynucleotide targeted against the type II regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects
28. Identification and differential expression of two forms of regulatory subunits (RII) of cAMP-dependent protein kinase II in Friend erythroleukemic cells
29. Compensatory stabilization of RIIβ protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIα protein
30. Therapeutic applications of oligonucleotides
31. Antitumor activity of a phosphorothioate antisense oligonucleotide targeted against c-raf kinase
32. Cyclic AMP and the induction of eukaryotic gene transcription
33. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene
34. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence
35. Nerve growth factor activates a ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB
36. Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals
37. Inactivation of Bcl-2 by phosphorylation
38. Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of Bcl-2
39. Angiotensis type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis
40. Bcl-2 phosphorylation required for anti-apoptosis function
41. Interkeukin-3 and h?-1 mediate hyperphosphorylation of Bcl2α in association with suppression of apoptosis
42. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
43. Bcl-2 heterodimerizes in vivo with a conserved homolog. Bax, that accelerates programmed cell death
44. Interaction among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system
45. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells